Aoxing Pharmaceutical Company Inc (AOXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 5,702 | 8,009 | 7,569 | 8,825 | 6,564 |
| Cost of Goods | 1,281 | 1,713 | 1,515 | 2,661 | 1,630 |
| Gross Profit | 4,421 | 6,297 | 6,054 | 6,165 | 4,934 |
| Operating Expenses | 3,824 | 6,776 | 4,866 | 8,673 | 4,037 |
| Operating Income | 878 | 233 | 1,704 | -1,848 | 1,527 |
| Interest Expense | 650 | 640 | 657 | 947 | 601 |
| Other Income | 69 | 17 | -4 | -26 | -110 |
| Pre-tax Income | 297 | -390 | 1,043 | -2,821 | 816 |
| Income Tax | 154 | -357 | 651 | -857 | 146 |
| Net Income Continuous | 143 | -33 | 392 | -1,964 | 670 |
| Minority Interests | 11 | 11 | 46 | -65 | 48 |
| Net Income | $132 | $-44 | $346 | $-1,898 | $623 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.00 | -0.03 | 0.01 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.01 | -0.03 | 0.01 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.00 | -0.03 | 0.01 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.01 | -0.03 | 0.01 |
| EBITDA(a) | $1,121 | $485 | $1,948 | $-1,601 | $1,777 |